Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Almer

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Gut|January 1, 1993
Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's diseaseE Peen, S Almer, G Bodemar, et al.
Scandinavian Journal of Gastroenterology|December 1, 1992
Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis?S Almer, L Franzén, A M Peters, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organismsLaurel S Almer, Jennifer B Hoffrage, Erika L Keller, et al.
Lancet (London, England)|August 30, 2000
Mycophenolate mofetil in Crohn's diseaseD S Rampton, M F Neurath, S Almer, et al.
Gut|March 18, 2006
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel diseaseU Hindorf, M Lindqvist, C Peterson, et al.
Scandinavian Journal of Gastroenterology|February 24, 2001
Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitisH Hjortswang, G Järnerot, B Curman, et al.
The American Journal of Gastroenterology|June 23, 2001
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel diseaseS Levenstein, Z Li, S Almer, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
The epidemiology and clinical features of portal vein thrombosis: a multicentre studyR Rajani, E Björnsson, A Bergquist, et al.
Digestive Diseases and Sciences|September 1, 1995
Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control studyJ Aisenberg, J Wagreich, J Shim, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococciVirginia D Shortridge, Ping Zhong, Zhensheng Cao, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Gut|January 1, 1993
Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's diseaseE Peen, S Almer, G Bodemar, et al.
Scandinavian Journal of Gastroenterology|December 1, 1992
Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis?S Almer, L Franzén, A M Peters, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organismsLaurel S Almer, Jennifer B Hoffrage, Erika L Keller, et al.
Lancet (London, England)|August 30, 2000
Mycophenolate mofetil in Crohn's diseaseD S Rampton, M F Neurath, S Almer, et al.
Gut|March 18, 2006
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel diseaseU Hindorf, M Lindqvist, C Peterson, et al.
Scandinavian Journal of Gastroenterology|February 24, 2001
Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitisH Hjortswang, G Järnerot, B Curman, et al.
The American Journal of Gastroenterology|June 23, 2001
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel diseaseS Levenstein, Z Li, S Almer, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
The epidemiology and clinical features of portal vein thrombosis: a multicentre studyR Rajani, E Björnsson, A Bergquist, et al.
Digestive Diseases and Sciences|September 1, 1995
Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control studyJ Aisenberg, J Wagreich, J Shim, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococciVirginia D Shortridge, Ping Zhong, Zhensheng Cao, et al.
Pageof 7